A Cancer Doc Weighs In On CAR-T, Precision Medicine And Pricing Debates – Forbes
Forbes |
A Cancer Doc Weighs In On CAR–T, Precision Medicine And Pricing Debates
Forbes But leukemia is just the beginning for this class of cancer treatment, which involves removing immune cells from individual patients and then engineering them to seek out and destroy their cancers. These chimeric antigen receptor T–cell (CAR-T … |
